Apratoxin D, a Potent Cytotoxic Cyclodepsipeptide from Papua New Guinea Collections of the Marine Cyanobacteria Lyngbya majuscula and Lyngbya sordida
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Cancer cell toxicity-guided fractionation of extracts of the Papua New Guinea marine cyanobacteria Lyngbya majuscula and Lyngbya sordida led to the isolation of apratoxin D (1). Compound 1 contains the same macrocycle as apratoxins A and C but possesses the novel 3,7-dihydroxy-2,5,8,10,10-pentamethylundecanoic acid as the polyketide moiety. The planar structures and stereostructures of compound 1 were determined by extensive 1D and 2D NMR and MS data analyses and by comparison with the spectroscopic data of apratoxins A and C. Apratoxin D (1) showed potent in vitro cytotoxicity against H-460 human lung cancer cells with an IC 50 value of 2.6 nM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Luesch, H., Yoshida, W. Y., Moore, R. E., Paul, V. J., & Corbett, T. H. (2001) · Journal of the American Chemical Society · doi:10.1021/ja010453j · Cited by 373
Ma, D., Zou, B., Cai, G., Hu, X., & Liu, J. O. (2006) · Chemistry – A European Journal · doi:10.1002/chem.200600599 · Cited by 99
Cited by
Faulkner, D. J. (1990) · Natural Product Reports · doi:10.1039/np9900700269 · Cited by 4,866
Construction of sulfur-containing moieties in the total synthesis of natural products
Wang, N., Saidhareddy, P., & Jiang, X. (2020) · Natural Product Reports · doi:10.1039/c8np00093j · Cited by 750
Molecular Networking as a Dereplication Strategy
Yang, J. Y., Sanchez, L. M., Rath, C. M., Liu, X., Boudreau, P. D., Bruns, N., Glukhov, E., Wodtke, A., de Felicio, R., Fenner, A., et al. (2013) · Journal of Natural Products · doi:10.1021/np400413s · Cited by 607
Self-citationBlunt, J. W., Copp, B. R., Keyzers, R. A., Munro, M. H. G., & Prinsep, M. R. (2014) · Natural Product Reports · doi:10.1039/c3np70117d · Cited by 484
Blunt, J. W., Copp, B. R., Munro, M. H. G., Northcote, P. T., & Prinsep, M. R. (2010) · Natural Product Reports · doi:10.1039/b906091j · Cited by 406
Singh, R., Parihar, P., Singh, M., Bajguz, A., Kumar, J., Singh, S., Singh, V. P., & Prasad, S. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00515 · Cited by 398
Muscarine, imidazole, oxazole, and thiazole alkaloids
Jin, Z. (2011) · Natural Product Reports · doi:10.1039/c0np00074d · Cited by 311
Biologically active secondary metabolites from marine cyanobacteria
Nunnery, J. K., Mevers, E., & Gerwick, W. H. (2010) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2010.09.019 · Cited by 265
Self-citationBioactive Compounds Isolated from Microalgae in Chronic Inflammation and Cancer
Talero, E., García-Mauriño, S., Ávila-Román, J., Rodríguez-Luna, A., Alcaide, A., & Motilva, V. (2015) · Marine Drugs · doi:10.3390/md13106152 · Cited by 255
Pharmaceutical applications of cyanobacteria—A review
Vijayakumar, S., & Menakha, M. (2015) · Journal of Acute Medicine · doi:10.1016/j.jacme.2015.02.004 · Cited by 205
Marine cyanobacteria compounds with anticancer properties: A review on the implication of apoptosis
Costa, M., Costa-Rodrigues, J., Fernandes, M. H., Barros, P., Vasconcelos, V., & Martins, R. (2012) · Marine Drugs · doi:10.3390/md10102181 · Cited by 147
Antitumor Peptides from Marine Organisms
Zheng, L.-H., Wang, Y.-J., Sheng, J., Wang, F., Zheng, Y., Lin, X.-K., & Sun, M. (2011) · Marine Drugs · doi:10.3390/md9101840 · Cited by 146
“Some other antitumor peptides including Symplocamide A [125,126], Apratoxin D [127,128] and Mitsoamide [129] have been isolated recently from Cyanobacteria.”
BackgroundCyanotherapeutics: An emerging field for future drug discovery
Tiwari, A. K., & Tiwari, B. S. (2020) · Applied Phycology · doi:10.1080/26388081.2020.1744480 · Cited by 49
Metadata
- Authors
- Gutiérrez, M., Suyama, T. L., Engene, N., Wingerd, J. S., Matainaho, T., & Gerwick, W. H.
- Venue
- Journal of Natural Products
- Publisher
- American Chemical Society (ACS)
- Published
- 2008-04-30
- Volume
- 71
- Issue
- 6
- Pages
- 1099-1103
- ISSN
- 0163-3864 (ISSN-L)
- 1520-6025
- OpenAlex
- W2012418547
- Cited by
- 156
- References
- 2
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.